SCHEMBL2198605

SCHEMBL2198605

Cc1ccc(CO[Si](C(C)C)(C(C)C)C(C)C)cc1C(=O)c1ccc(Br)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 4/20 0.39
MAPK12 P53778 4/20 0.39
MAPK11 Q15759 4/20 0.39
MAPK14 Q16539 4/20 0.39
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
UTS2R Q9UKP6 1/20 0.34
ALDH1A1 P00352 3/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
HPGD P15428 1/20 0.34
PARP1 P09874 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
MAPK1 P28482 1/20 0.33
ITGB1 P05556 1/20 0.32
ITGA4 P13612 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198828 0.87 MRGPRX4 (0.44) MEN1TSHRKMT2AALDH1A1LMNA
SCHEMBL2200086 0.77 MAPK13 (0.52) MAPK13MAPK12MAPK11MAPK14KMT2A
SCHEMBL2200059 0.76 MEN1 (0.32) MEN1TSHRKMT2A
SCHEMBL2857233 0.72 MAPK13 (0.52) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL506422 0.72 RXRA (0.47) ALDH1A1PARP1CYP4F2CYP4A11
SCHEMBL2196860 0.70 MAPK13 (0.46) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL506405 0.70 KDM4E (0.41) TSHRKMT2AALDH1A1LMNAHPGD
SCHEMBL2199850 0.69 MAPK13 (0.52) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL481295 0.69 IDO1 (0.47) MEN1KMT2AALDH1A1LMNAHTT
SCHEMBL2201647 0.68 SLC6A4 (0.36) MEN1TSHRKMT2ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.